ECB says unable to assess Iran war impact yet

The key market issue is not the conflict headline itself but the uncertainty premium it injects into near-term European growth, inflation, and energy-input assumptions. That combination is typically worst for cyclical euro assets because it delays capex and inventory decisions while keeping input-cost risk elevated, a mix that can compress margins before it materially shows up in top-line data. The ECB’s inability to size the shock argues for a data-gap regime where rates are less likely to be the immediate catalyst; instead, the first move is usually in relative equity performance and credit spreads.

The second-order winner is probably not energy producers in Europe but quality balance-sheet defensives and firms with pricing power, especially those with low direct energy intensity and non-domestic revenue exposure. European airlines, chemicals, autos, and discretionary retail are the most vulnerable if the situation keeps oil and insurance/shipping costs elevated for even a few weeks, because their earnings sensitivity is asymmetric: small input-cost increases can erase several quarters of margin recovery. Conversely, US multinationals and global healthcare/ staples should gain on a relative basis as capital rotates away from euro-area cyclicals and into lower-volatility cash-flow compounds.

The contrarian point is that the market may be overpricing a durable macro shock if the conflict remains contained and brief. In that case, the main trade is not a regime change but a short-lived risk-premium spike that fades within days to a couple of weeks, especially if energy prices retrace and ECB speakers pivot back to domestic inflation and wage data. The cleanest tell will be whether front-end European rates sell off on growth fear or the curve steepens on energy-driven inflation; if the latter dominates, duration underperforms less than cyclicals, which argues for being tactically selective rather than macro-bearish.